Intuitive Surgical, Inc. $ISRG Stock Sold by Park Avenue Securities LLC

Park Avenue Securities LLC trimmed its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.5% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 14,424 shares of the medical equipment provider’s stock after selling 1,878 shares during the period. Park Avenue Securities LLC’s holdings in Intuitive Surgical were worth $5,865,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. Segment Wealth Management LLC raised its holdings in Intuitive Surgical by 14.0% during the 3rd quarter. Segment Wealth Management LLC now owns 7,425 shares of the medical equipment provider’s stock worth $3,019,000 after purchasing an additional 909 shares during the last quarter. Verdence Capital Advisors LLC lifted its position in shares of Intuitive Surgical by 209.3% in the 3rd quarter. Verdence Capital Advisors LLC now owns 6,886 shares of the medical equipment provider’s stock worth $2,800,000 after purchasing an additional 4,660 shares during the period. Flagship Harbor Advisors LLC lifted its position in shares of Intuitive Surgical by 36.8% in the 3rd quarter. Flagship Harbor Advisors LLC now owns 2,703 shares of the medical equipment provider’s stock worth $1,099,000 after purchasing an additional 727 shares during the period. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA boosted its stake in shares of Intuitive Surgical by 235.8% in the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 138,050 shares of the medical equipment provider’s stock valued at $56,135,000 after purchasing an additional 96,938 shares during the last quarter. Finally, Aries Wealth Management boosted its stake in shares of Intuitive Surgical by 5.6% in the 3rd quarter. Aries Wealth Management now owns 1,224 shares of the medical equipment provider’s stock valued at $498,000 after purchasing an additional 65 shares during the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $444.18 on Thursday. The firm has a market cap of $153.97 billion, a PE ratio of 53.71, a price-to-earnings-growth ratio of 3.12 and a beta of 1.46. Intuitive Surgical, Inc. has a 52-week low of $328.57 and a 52-week high of $603.88. The business’s 50 day moving average price is $399.37 and its two-hundred day moving average price is $435.44.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, topping the consensus estimate of $2.65 by $0.35. The company had revenue of $3.05 billion during the quarter, compared to the consensus estimate of $2.91 billion. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The company’s quarterly revenue was up 21.7% on a year-over-year basis. During the same quarter last year, the firm posted $2.40 EPS. Research analysts predict that Intuitive Surgical, Inc. will post 9.37 EPS for the current fiscal year.

Key Headlines Impacting Intuitive Surgical

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Wall Street remains broadly bullish on ISRG. The consensus rating is “Moderate Buy,” with an average price target of $493.54, while Zacks recently upgraded the stock to “Strong Buy.” Raymond James and BTIG also reiterated positive ratings. Wall Street Views on Intuitive Surgical
• Positive Sentiment: Intuitive Surgical’s latest quarter showed solid demand: revenue rose 21.7% year over year to $3.05 billion, exceeding estimates, while earnings of $3.00 per share beat the $2.65 consensus. This supports the long-term growth case for its da Vinci robotic-surgery business. Intuitive Surgical Earnings and Valuation
• Neutral Sentiment: Recent performance has been mixed: the stock has rebounded over the past one to three months, but remains below its prior-year level. Investors are assessing whether continued procedure growth and higher estimates can justify ISRG’s premium valuation.
• Negative Sentiment: Several insiders reported stock sales, including EVP Mark Brosius, SVP Patricia Wadors, former CEO Gary Guthart and insider Fredrik Widman. Brosius sold shares in two transactions, while Guthart’s reported sale was approximately $9.1 million. The trades were made under pre-arranged Rule 10b5-1 plans, reducing their signaling value, but the volume of selling may weigh on sentiment. Gary Guthart Insider Sale
• Negative Sentiment: Despite the earnings beat, lower net income and earnings-per-share comparisons have highlighted margin pressure. With ISRG trading at a high earnings multiple, investors may be particularly sensitive to any slowdown in profitability or procedure growth. Why Intuitive Surgical’s Strong Quarter Spooked Investors

Analyst Upgrades and Downgrades

ISRG has been the subject of several recent analyst reports. HSBC cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective for the company. in a research report on Thursday, July 30th. UBS Group restated a “buy” rating on shares of Intuitive Surgical in a report on Tuesday, October 13th. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $450.00 to $475.00 and gave the company an “overweight” rating in a research report on Wednesday, October 21st. BTIG Research reiterated a “buy” rating and set a $454.00 price target on shares of Intuitive Surgical in a report on Wednesday, October 21st. Finally, Barclays reiterated an “overweight” rating and set a $500.00 price target (up from $485.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. One research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $493.54.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Gary Guthart sold 20,095 shares of the stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $451.61, for a total transaction of $9,075,102.95. Following the transaction, the director directly owned 1,204,530 shares of the company’s stock, valued at $543,977,793.30. This represents a 1.64% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Craig Barratt sold 1,150 shares of the firm’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $443.80, for a total transaction of $510,370.00. Following the completion of the sale, the director owned 1,150 shares of the company’s stock, valued at $510,370. The trade was a 50.00% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 38,806 shares of company stock valued at $16,824,795 over the last 90 days. Insiders own 0.60% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.